The new GLA-3M-052-LS+OVA vaccine can be delivered as a nasal spray. Three doses protected mice from infection from SARS-CoV-2 and other coronaviruses for three months, and reduced the viral load in ...
A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once.
The MarketWatch News Department was not involved in the creation of this content. A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data ...
Our immune system is divided into two main branches: innate and adaptive. Innate immune cells act as a first line of defense, quickly responding to invaders, while adaptive immune cells take a longer ...
Local News Matters on MSN
Stanford team develops 'universal vaccine' that protects against multiple infections
A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once. Traditionally, vaccines protect against one ...
Researchers develop nasal “universal vaccine” that shields mice from viruses, bacteria and allergens
Stanford Medicine researchers developed a nasal spray vaccine that protected mice against viruses, bacteria and allergens — a ...
An innovative approach supercharges the innate immune system to provide a first line of defence against respiratory ...
A comparison between a healthy brain (left) and a brain severely affected by Alzheimer’s disease (right). Alzheimer’s leads to significant shrinkage and loss of brain tissue, reflecting the damage ...
Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...
Cancer immunotherapies, including cancer vaccines, harness and amplify the immune system’s natural ability to detect and attack cancer cells. In this illustration, immune T cells (pink) attach to a ...
A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s proprietary TCR-antigen datasets for research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results